WuXi Biologics named in 2026 Dow Jones Best-in-Class World Index and Emerging Markets Index
Clearway Health recognised with 2026 Great Place To Work Certification for fourth consecutive year
Servier's Emi-Le receives US FDA breakthrough therapy designation for adenoid cystic carcinoma
Insilico Medicine enters strategic collaboration agreement with Ribo
Bavarian Nordic secures USD97m US vaccine contract expansion and raises 2026 outlook
Ranok Therapeutics reports positive Phase 1a clinical results for KRAS G12D inhibitor RNK08954
Avid Bioservices names new chief commercial officer
AnaCardio reports Phase 1b/2a data showing cardiac function gains with AC01
Inhibrx reports positive interim Phase 2 data for INBRX-106 in first-line head and neck cancer
Anixa Biosciences reports extended survival signals in Phase 1 ovarian cancer CAR-T trial
Oncopeptides plans EMA filing to broaden Pepaxti indication
GSK partners with SBP Group to accelerate China launch of bepirovirsen
Harbour BioMed's HBM7004 receives US FDA IND clearance for Phase I trial